Zhejiang East Asia Pharmaceutical Co. Ltd.
Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents… Read more
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.008x
Based on the latest financial reports, Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) has a cash flow conversion efficiency ratio of -0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.16 Million) by net assets (CN¥1.81 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang East Asia Pharmaceutical Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Zhejiang East Asia Pharmaceutical Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang East Asia Pharmaceutical Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang East Asia Pharmaceutical Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LUBAWA SA
WAR:LBW
|
0.058x |
|
Bajaj Hindusthan Sugar Limited
NSE:BAJAJHIND
|
-0.007x |
|
PT Map Aktif Adiperkasa Tbk
F:JN4
|
N/A |
|
BCEG Environmental Remediation Co. Ltd.
SHE:300958
|
N/A |
|
Greaves Cotton Limited
NSE:GREAVESCOT
|
-0.052x |
|
Guangdong AVCiT Tech Hldg Co
SHE:001229
|
0.026x |
|
Addcn Technology Co Ltd
TWO:5287
|
0.103x |
|
Aeluma, Inc
NASDAQ:ALMU
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Zhejiang East Asia Pharmaceutical Co. Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang East Asia Pharmaceutical Co. Ltd. from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.87 Billion | CN¥-156.55 Million | -0.084x | -100.19% |
| 2023-12-31 | CN¥2.02 Billion | CN¥-84.06 Million | -0.042x | -9.09% |
| 2022-12-31 | CN¥1.84 Billion | CN¥-70.35 Million | -0.038x | -184.86% |
| 2021-12-31 | CN¥1.76 Billion | CN¥-23.60 Million | -0.013x | -115.80% |
| 2020-12-31 | CN¥1.73 Billion | CN¥146.90 Million | 0.085x | -66.75% |
| 2019-12-31 | CN¥848.04 Million | CN¥216.63 Million | 0.255x | +26.42% |
| 2018-12-31 | CN¥710.90 Million | CN¥143.64 Million | 0.202x | +39.35% |
| 2017-12-31 | CN¥632.13 Million | CN¥91.66 Million | 0.145x | +13.74% |
| 2016-12-31 | CN¥426.33 Million | CN¥54.35 Million | 0.127x | -- |